Literature DB >> 2715795

Structural requirements of Na+-dependent antidopaminergic agents: Tropapride, Piquindone, Zetidoline, and Metoclopramide. Comparison with Na+-independent ligands.

S Collin1, D P Vercauteren, D Vanderveken, G Evrard, F Durant.   

Abstract

Molecular graphic design coupled with PCILO and crystallographic results have been used to investigate the three-dimensional structure of Tropapride, Piquindone, Zetidoline, and Metoclopramide, four dopamine D-2 receptor antagonists showing Na+-dependent binding. Three putative pharmacophoric elements, a nitrogen lone pair, a phenyl ring and a carbonyl moiety, are similarly oriented in all the Na+-dependent drugs. Conversely, for Na+-independent analogs, the two latter pharmacophoric elements play a subordinate role, but two pi-electron regions are systematically localized on the other side of the molecule: the first is a phenyl group while the second is a carbonyl function as in butyrophenones, a cyano group as in R48455, or a phenyl ring as in diphenylbutylpiperidines or tricyclics. The presence of a benzyl ring on this side in Tropapride might explain its weak extrapyramidal effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715795     DOI: 10.1007/BF01590994

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  12 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  A comparison between the conformation of dexclamol and the tricyclic and butyrophenone type dopamine antagonists.

Authors:  H Moereels; J P Tollenaere
Journal:  Life Sci       Date:  1978-08-07       Impact factor: 5.037

3.  Biochemical and pharmacological activities of zetidoline (DL 308-IT): a new antidopaminergic agent.

Authors:  D Barone; N Corsico; A Diena; A Restelli; A Glässer; F Rodenghi
Journal:  J Pharm Pharmacol       Date:  1982-02       Impact factor: 3.765

4.  A dopamine receptor model and its application in the design of a new class of rigid pyrrolo[2,3-g]isoquinoline antipsychotics.

Authors:  G L Olson; H C Cheung; K D Morgan; J F Blount; L Todaro; L Berger; A B Davidson; E Boff
Journal:  J Med Chem       Date:  1981-09       Impact factor: 7.446

5.  Investigation on central dopaminergic receptors (D-2) using the antagonistic properties of new benzamides.

Authors:  J F Rumigny; M Strolin Benedetti; P Dostert
Journal:  J Pharm Pharmacol       Date:  1984-06       Impact factor: 3.765

6.  Neuropharmacological profile of MD 790501, a new benzamide derivative.

Authors:  M Jalfre; B Bucher; N Dorme; G Mocquet; R D Porsolt
Journal:  Arch Int Pharmacodyn Ther       Date:  1983-08

7.  Characterization of [3H]zetidoline binding to rat striatal membranes.

Authors:  D Barone; A Assandri; G Galliani; A Glässer; G Tarzia
Journal:  J Pharm Pharmacol       Date:  1985-03       Impact factor: 3.765

8.  Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.

Authors:  A E Theodorou; M D Hall; P Jenner; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1980-06       Impact factor: 3.765

9.  Synthesis of new psychotropic 2-imidazolidinones.

Authors:  L Fontanella; N Corsico; A Diena; G Galliani; A Glässer
Journal:  Farmaco Sci       Date:  1981-01

10.  Stereoelectronic study of zetidoline, a dopamine D2 receptor antagonist.

Authors:  S Collin; G Evrard; D P Vercauteren; F Durant; P A Carrupt; H van de Waterbeemd; B Testa
Journal:  J Med Chem       Date:  1989-01       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.